Joint Program in Spinal Muscular Atrophy Enters First Stage of Clinical Development
SOUTH PLAINFIELD, NJ, Jan. 22, 2014 – (CRWE Press Release) – PTC Therapeutics, Inc. (NASDAQ: PTCT), the SMA Foundation, and Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today…

